Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L F Fabre

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Psychiatry|September 1, 1990
Buspirone in the management of major depression: a placebo-controlled comparisonL F Fabre
The Journal of Clinical Psychiatry|February 1, 1992
A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatientsL F Fabre
Clinical Neuropharmacology|January 1, 1989
United States experience and perspectives with trazodoneL F Fabre
The Journal of Clinical Psychiatry|December 1, 1985
Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotilineL F Fabre
Current Therapeutic Research, Clinical and Experimental|June 1, 1976
Pilot open label study with alprazolam (U31, 889) in outpatients with neurotic depressionL F Fabre
The Journal of Clinical Psychiatry|September 1, 1990
Trazodone dosing regimen: experience with single daily administrationL F Fabre
Journal of Clinical Pharmacology|August 1, 1981
The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxietyL F Fabre, D McLendon
Current Therapeutic Research, Clinical and Experimental|September 1, 1974
Pilot open-label study on U-31,889 in anxious in-patientsL F Fabre, R T Harris
The Journal of Clinical Psychiatry|May 1, 1988
Depressive symptoms and intellectual functioning in anxiety patients treated with clorazepateL F Fabre, H P Putman
Current Therapeutic Research, Clinical and Experimental|August 1, 1974
Pilot open-label study on U-28,774, in anxious in-patientsL F Fabre, R T Harris
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Psychiatry|September 1, 1990
Buspirone in the management of major depression: a placebo-controlled comparisonL F Fabre
The Journal of Clinical Psychiatry|February 1, 1992
A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatientsL F Fabre
Clinical Neuropharmacology|January 1, 1989
United States experience and perspectives with trazodoneL F Fabre
The Journal of Clinical Psychiatry|December 1, 1985
Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotilineL F Fabre
Current Therapeutic Research, Clinical and Experimental|June 1, 1976
Pilot open label study with alprazolam (U31, 889) in outpatients with neurotic depressionL F Fabre
The Journal of Clinical Psychiatry|September 1, 1990
Trazodone dosing regimen: experience with single daily administrationL F Fabre
Journal of Clinical Pharmacology|August 1, 1981
The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxietyL F Fabre, D McLendon
Current Therapeutic Research, Clinical and Experimental|September 1, 1974
Pilot open-label study on U-31,889 in anxious in-patientsL F Fabre, R T Harris
The Journal of Clinical Psychiatry|May 1, 1988
Depressive symptoms and intellectual functioning in anxiety patients treated with clorazepateL F Fabre, H P Putman
Current Therapeutic Research, Clinical and Experimental|August 1, 1974
Pilot open-label study on U-28,774, in anxious in-patientsL F Fabre, R T Harris
Pageof 6